We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+38.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$617M
AUM Growth
+$270M
Cap. Flow
+$176M
Cap. Flow %
28.52%
Top 10 Hldgs %
38.27%
Holding
109
New
46
Increased
22
Reduced
16
Closed
21

Top Buys

1
ZBH icon
Zimmer Biomet
ZBH
+$15.9M
2
ABT icon
Abbott
ABT
+$12.9M
3
DBVT
DBV Technologies
DBVT
+$8.68M
4
CELG
Celgene Corp
CELG
+$8.12M
5
CYNO
Cynosure, Inc. Class A
CYNO
+$7.79M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$12.1M
2
MDT icon
Medtronic
MDT
+$8.68M
3
BLUE
bluebird bio
BLUE
+$6.15M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.68M
5
CNMD icon
CONMED
CNMD
+$5.52M

Sector Composition

1 Healthcare 51.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
51
DELISTED
bluebird bio
BLUE
$4.07M 0.66%
4,632
-8,492
-65% -$6.15M
ELGX
52
DELISTED
Endologix Inc
ELGX
$3.84M 0.62%
30,000
-10,000
-25% -$1.28M
ZGNX
53
DELISTED
Zogenix, Inc.
ZGNX
$3.71M 0.6%
+325,000
New +$3M
KITE
54
CALL
DELISTED
Kite Pharma, Inc.
KITE
$3.63M 0.59%
+65,000
New +$3.62M
NGNE icon
55
Neurogene
NGNE
$744M
$3.34M 0.54%
+12,500
New +$2.52M
TMO icon
56
Thermo Fisher Scientific
TMO
$198B
$3.18M 0.52%
+20,000
New +$3.08M
KTWO
57
DELISTED
K2M Group Holdings, Inc
KTWO
$3.11M 0.5%
175,000
-175,000
-50% -$2.94M
CYH icon
58
CALL
Community Health Systems
CYH
$465M
$2.88M 0.47%
+250,000
New +$2.88M
EXAS
59
DELISTED
Exact Sciences
EXAS
$2.79M 0.45%
+150,000
New +$2.64M
VCYT icon
60
Veracyte
VCYT
$4.72B
$2.77M 0.45%
364,000
+22,292
+7% +$126K
AKBA icon
61
Akebia Therapeutics
AKBA
$359M
$2.71M 0.44%
+300,000
New +$2.55M
XENE icon
62
Xenon Pharmaceuticals
XENE
$6.6B
$2.63M 0.43%
+325,000
New +$2.51M
RIGL icon
63
Rigel Pharmaceuticals
RIGL
$750M
$2.57M 0.42%
70,000
-10,000
-13% -$287K
NDRM
64
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$2.42M 0.39%
+131,000
New +$2.27M
GHDX
65
DELISTED
Genomic Health, Inc.
GHDX
$2.17M 0.35%
75,000
-125,000
-63% -$3.48M
DVAX
66
CALL
DELISTED
Dynavax Technologies
DVAX
$2.1M 0.34%
+200,000
New +$2.87M
ISEE
67
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.01M 0.33%
+43,600
New +$2.46M
VNDA icon
68
Vanda Pharmaceuticals
VNDA
$327M
$1.85M 0.3%
+111,000
New +$1.49M
MRTX
69
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.82M 0.29%
275,000
+200,000
+267% +$1.06M
CNMD icon
70
CONMED
CNMD
$1.3B
$1.8M 0.29%
45,000
-130,000
-74% -$5.52M
TSRO
71
DELISTED
TESARO, Inc.
TSRO
$1.7M 0.28%
17,000
-33,000
-66% -$3.08M
TXMD icon
72
TherapeuticsMD
TXMD
$23.8M
$1.7M 0.28%
+5,000
New +$1.83M
RCKT icon
73
Rocket Pharmaceuticals
RCKT
$376M
$1.61M 0.26%
+42,500
New +$1.34M
ARCT icon
74
Arcturus Therapeutics
ARCT
$172M
$1.61M 0.26%
92,857
+50,000
+117% +$1.62M
FOMX
75
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.46M 0.24%
+157,962
New +$1.32M
1 2
3
4 5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Ghost Tree Capital held 109 positions worth $617M, up 78% from $346M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ghost Tree Capital deployed $176M of net new capital in Q3 2016, opening 46 new positions and adding to 22 existing holdings. Its largest new stake was Zimmer Biomet: 128,750 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 56% a quarter earlier.

On the sell side, the largest reduction was bluebird bio, an estimated $6.15M trimmed.

  • Ghost Tree Capital's largest Q3 2016 buy was Zimmer Biomet: 128,750 shares worth $16.3M.
  • Ghost Tree Capital added most to Celgene Corp in Q3 2016, an estimated $8.12M increase.
  • Ghost Tree Capital's biggest Q3 2016 reduction was bluebird bio, cutting an estimated $6.15M.
  • Ghost Tree Capital fully exited IVERIC bio, Inc. Common Stock in Q3 2016, selling an estimated $12.1M.
  • Ghost Tree Capital's ten largest holdings make up 38% of its $617M portfolio in Q3 2016.
  • Ghost Tree Capital opened 46 new positions and closed 21 in Q3 2016.
  • Ghost Tree Capital's portfolio value rose 78% quarter-over-quarter to $617M.

Based on Ghost Tree Capital's 13F filing for Q3 2016, filed 14 Nov 2016.